发明名称 |
Method for treatment with bucindolol based on genetic targeting |
摘要 |
<p>The present invention concerns the use of methods for evaluating bucindolol treatment for a patient, particularly one with heart failure. It concerns methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient is homozygous for the Arg 389 polymorphism in the ²1-adrenergic receptor (AR).</p> |
申请公布号 |
AU2005284822(B2) |
申请公布日期 |
2011.03.24 |
申请号 |
AU20050284822 |
申请日期 |
2005.09.14 |
申请人 |
REGENTS OF THE UNIVERSITY OF COLORADO |
发明人 |
STEPHEN B. LIGGETT;MICHAEL BRISTOW |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|